Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.
2025 · 3rd Quarter (July 1 - Sep 30)
CIGNA CORPORATION AND SUBSIDIARIES
Filed by TIBER CREEK GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2025
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- TIBER CREEK GROUP
- Filing UUID
- fb1ae714-2203-4a03-aa4e-989ec14cf5a4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability; Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to competition in the health care marketplace.
Pharmacy issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Pharmacy issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.